The U95 protein of human herpesvirus 6B interacts with human GRIM-19: Silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential

Journal of Virology

Volumn 82, Issue 2, 2008, Pages 1011-1020

  Yeo, W M ^a   Isegawa, Yuji ^b   Chow, Vincent T K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; GRIM 19 PROTEIN; HYBRID PROTEIN; INTERFERON; MESSENGER RNA; MYC PROTEIN; MYELIN; PROTEIN U95; RETINOIC ACID; RETINOID; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BONE MARROW; CELL DEATH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA LIBRARY; GENE EXPRESSION; GENE SILENCING; GENETIC CODE; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B; IMMEDIATE EARLY GENE; IMMUNOLOCALIZATION; IMMUNOPRECIPITATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION SWELLING; MOLECULAR INTERACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TWO HYBRID SYSTEM; ULTRASTRUCTURE; VIRUS LOAD;

APOPTOSIS REGULATORY PROTEINS; CELL LINE; GENE SILENCING; GIANT CELLS; HERPESVIRUS 6, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MITOCHONDRIA; MITOCHONDRIAL SWELLING; NADH, NADPH OXIDOREDUCTASES; PROTEIN BINDING; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL LOAD;

HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B;

EID: 37849048268     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01156-07     Document Type: Article

References (45)

1. Ablashi, D. V., N. Balachandran, S. F. Josephs, C. L. Hung, G. R. Krueger, B. Kramarsky, S. Z. Salahuddin, and R. C. Gallo. 1991. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184:545-552.
2. Andrews, H. E., P. P. Nichols, D. Bates, and D. M. Turnbull. 2005. Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis. Med. Hypotheses 64:669-677.
3. Angell, J. E., D. J. Lindner, P. S. Shapiro, E. R. Hofmann, and D. V. Kalvakolanu. 2000. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J. Biol. Chem. 275:33416-33426.
4. Arvin, A., G. Campadielli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, and K. Yamanishi (ed.). 2007. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
5. Ashshi, A. M., R. J. Cooper, P. E. Klapper, O. Al-Jiffri, and L. Moore. 2000. Detection of human herpes virus 6 DNA in fetal hydrops. Lancet 355:1519-1520.
6. Barnich, N., T. Hisamatsu, J. E. Aguirre, R. Xavier, H. C. Reinecker, and D. K. Podolsky. 2005. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 280:19021-19026.
7. Cardin, R. D., G. B. Abenes, C. A. Stoddart, and E. S. Mocarski. 1995. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236-241.
8. Charlot, J. F., J. L. Pretet, C. Haughey, and C. Mougin. 2004. Mitochondrial translocation of p53 and mitochondrial membrane potential dissipation are early events in staurosporine-induced apoptosis of wild type and mutated p53 epithelial cells. Apoptosis 9:333-343.
9. D'Agostino, D. M., P. Bernardi, L. Chieco-Bianchi, and V. Ciminale. 2005. Mitochondria as functional targets of proteins coded by human tumor viruses. Adv. Cancer Res. 94:87-142.
10. Dominguez, G., T. R. Dambaugh, F. R. Stamey, S. Dewhurst, N. Inoue, and P. E. Pellett. 1999. Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol. 73:8040-8052.
11. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129-134.
12. Galluzzi, L., N. Zamzami, T. de La Motte Rouge, C. Lemaire, C. Brenner, and G. Kroemer. 2007. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis 12:803-813.
13. Geng, Y. Q., B. Chandran, S. F. Josephs, and C. Wood. 1992. Identification and characterization of a human herpesvirus 6 gene segment that transactivates the human immunodeficiency virus type 1 promoter. J. Virol. 66:1564-1570.
14. Gompels, U. A., J. Nicholas, G. Lawrence, M. Jones, B. J. Thomson, M. E. Martin, S. Efstathiou, M. Craxton, and H. A. Macaulay. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
15. Huang, G., H. Lu, A. Hao, D. C. Ng, S. Ponniah, K. Guo, C. Lufei, Q. Zeng, and X. Cao. 2004. GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol. Cell. Biol. 24:8447-8456.
16. Huang, G., Y. Chen, H. Lu, and X. Cao. 2007. Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ. 14:327-337.
17. Inoue, Y., M. Yasukawa, and S. Fujita. 1997. Induction of T-cell apoptosis by human herpesvirus 6. J. Virol. 71:3751-3759.
18. Isegawa, Y., T. Mukai, K. Nakano, M. Kagawa, J. Chen, Y. Mori, T. Sunagawa, K. Kawanishi, J. Sashihara, A. Hata, P. Zou, H. Kosuge, and K. Yamanishi. 1999. Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J. Virol. 73:8053-8063.
19. Isegawa, Y., M. Takemoto, K. Yamanishi, A. Ohshima, and N. Sugimoto. 2007. Real-time PCR determination of human herpesvirus 6 antiviral drug susceptibility. J. Virol. Methods 140:25-31.
20. Janelle, M. E., and L. Flamand. 2006. Phenotypic alterations and survival of monocytes following infection by human herpesvirus-6. Arch. Virol. 151: 1603-1614.
21. Kikuta, H., A. Nakane, H. Lu, Y. Taguchi, T. Minagawa, and S. Matsumoto. 1990. Interferon induction by human herpesvirus 6 in human mononuclear cells. J. Infect. Dis. 162:35-38.
22. Kondo, K., T. Kondo, T. Okuno, M. Takahashi, and K. Yamanishi. 1991. Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol. 72:1401-1408.
23. Krueger, G., and D. V. Ablashi (ed.). 2006. Human herpesvirus-6: general virology, epidemiology and clinical pathology, 2nd ed., vol. 12. Elsevier Science, Oxford, United Kingdom.
24. Kumleh, H. H., G. H. Riazi, M. Houshmand, M. H. Sanati, K. Gharagozli, and M. Shafa. 2006. Complex I deficiency in Persian multiple sclerosis patients. J. Neurol. Sci. 243:65-69.
25. Leong, W. F., and V. T. Chow. 2006. Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell. Microbiol. 8:565-580.
26. Lim, K. M., W. S. Yeo, and V. T. Chow. 2004. Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle. Int. J. Cancer 109:24-37.
27. Mayne, M., C. Cheadle, S. S. Soldan, C. Cermelli, Y. Yamano, N. Akhyani, J. E. Nagel, D. D. Taub, K. G. Becker, and S. Jacobson. 2001. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol. 75:11641-11650.
28. Merelli, E., P. Sola, P. Barozzi, and G. Torelli. 1996. An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection. J. Neurol. Sci. 137:42-46.
29. Miguet-Alfonsi, C., C. Prunet, S. Monier, G. Bessede, S. Lemaire-Ewing, A. Berthier, F. Menetrier, D. Neel, P. Gambert, and G. Lizard. 2002. Analysis of oxidative processes and of myelin figures formation before and after the loss of mitochondrial transmembrane potential during 7-beta-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals. Biochem. Pharmacol. 64:527-541.
30. Mills, E. M., D. Xu, M. M. Fergusson, C. A. Combs, Y. Xu, and T. Finkel. 2002. Regulation of cellular oncosis by uncoupling protein 2. J. Biol. Chem. 277:27385-27392.
31. Morrison, M. L., K. Williamson, K. Arthur, G. J. Price, P. W. Hamilton, and P. Maxwell. 2005. Phenotypic changes in mitochondrial membrane potential during valinomycin-induced depolarisation and apoptosis. Cell. Oncol. 27:231-236.
32. Nicholas, J., and M. E. Martin. 1994. Nucleotide sequence analysis of a 38.5-kilobase-pair region of the genome of human herpesvirus 6 encoding human cytomegalovirus immediate-early gene homologs and transactivating functions. J. Virol. 68:597-610.
33. Raftery, M., A. Muller, and G. Schonrich. 2000. Herpesvirus homologues of cellular genes. Virus Genes 21:65-75.
34. Schirmer, E. C., L. S. Wyatt, K. Yamanishi, W. J. Rodriguez, and N. Frenkel. 1991. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc. Natl. Acad. Sci. USA 88:5922-5926.
35. Seo, T., D. Lee, Y. S. Shim, J. E. Angell, N. V. Chidambaram, D. V. Kalvakolanu, and J. Choe. 2002. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J. Virol. 76:8797-8807.
36. Shapiro, H. M. 2000. Membrane potential estimation by flow cytometry. Methods 21:271-279.
37. Shishido, S., H. Koga, M. Harada, H. Kumemura, S. Hanada, E. Taniguchi, R. Kumashiro, H. Ohira, Y. Sato, M. Namba, T. Ueno, and M. Sata. 2003. Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 37:136-147.
38. Sim, D. L., W. M. Yeo, and V. T. Chow. 2002. The novel human HUEL (C4orf1) protein shares homology with the DNA-binding domain of the XPA DNA repair protein and displays nuclear translocation in a cell cycle-dependent manner. Int. J. Biochem. Cell. Biol. 34:487-504.
39. Takahashi, K., S. Sonoda, K. Higashi, T. Kondo, H. Takahashi, M. Takahashi, and K. Yamanishi. 1989. Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol. 63:3161-3163.
40. Takemoto, M., T. Shimamoto, Y. Isegawa, and K. Yamanishi. 2001. The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J. Virol. 75:10149-10160.
41. Tan, E. L., T. M. Tan, V. T. Chow, and C. L. Poh. 2007. Enhanced potency and efficacy of 29-mer shRNAs in inhibition of enterovirus 71. Antivir. Res. 74:9-15.
42. Thompson, J., S. Choudhury, F. Kashanchi, J. Doniger, Z. Berneman, N. Frenkel, and L. J. Rosenthal. 1994. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 9:1167-1175.
43. Thomson, B. J., and R. W. Honess. 1992. The right end of the unique region of the genome of human herpesvirus 6 U1102 contains a candidate immediate early gene enhancer and a homologue of the human cytomegalovirus US22 gene family. J. Gen. Virol. 73:1649-1660.
44. Yamamoto, T., T. Mukai, K. Kondo, and K. Yamanishi. 1994. Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. J. Clin. Microbiol. 32:473-476.
45. Yeo, W. M., and V. T. Chow. 2007. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat. Microb. Pathog. 42:129-137.